Genmab A/S

Public limited companyCVR 21023884ValbyActive

Genmab A/S is a public limited company, based in Valby, active in research and experimental development on natural sciences and engineering, founded in 1998. Net profit fell 88% from 2024 to 2025, ending at DKK 963m. With 676 employees, the company is about 135 times larger than the industry median. Equity fell to DKK 5.8bn in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 3.7bn−82.7% vs. 2024
Net profitDKK 963m−87.7% vs. 2024
EquityDKK 5.8bn−84.1% vs. 2024
Employees676latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Revenue fell 83% (2024 → 2025), to DKK 3.7bn.
  • Net profit fell 88% (2024 → 2025), to DKK 963m.
  • Equity fell 84% (2024 → 2025), to DKK 5.8bn.

Employees

  • 109 more employees than a year earlier: 676 (07/2026) against 567 (07/2025).

Management and owners, last 24 months

  • New in management: Ogi Takahashi (deputy board member, 12/03/2025), Martha Theresa Ramirez-Andersen (deputy board member, 12/03/2025) and Gina Theresa Schweizer (board member, 15/08/2026) (+2).
  • Stepped down: Julie Blædel (deputy board member, 12/03/2025), Richard Gordon Hibbert (deputy board member, 12/03/2025) and Takahiro Hamatani (board member, 12/03/2025) (+2).
  • New owners registered: Darwin Global Management Limited (28/09/2026).

Registrations, last 24 months

  • 08/09/2026: Share capital changed from 62,377,844 DKK to 62,405,855 DKK
  • 11/08/2026: Share capital changed from 62,353,252 DKK to 62,377,844 DKK
  • 16/06/2026: Share capital changed from 62,353,067 DKK to 62,353,252 DKK
  • 12/05/2026: Share capital changed from 62,350,721 DKK to 62,353,067 DKK
  • 17/04/2026: Share capital changed from 64,250,721 DKK to 62,350,721 DKK
  • 24/02/2026: Share capital changed from 64,238,408 DKK to 64,250,721 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2017–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 5bnDKK 10bnDKK 15bnDKK 20bnDKK 25bnDKK 30bnDKK 35bn201720182019202020212022202320242025
EquityNet profit
Financial figures for Genmab A/S
201720182019202020212022202320242025Change
Revenue2,365,4363,025,1375,366,00010,111,0008,482,00014,595,00016,474,00021,526,0003,720,000−82.7%
Operating profit (EBIT)1,344,1711,380,2832,638,0006,313,0003,018,0006,357,0005,321,0006,703,0001,065,000−84.1%
Profit before tax1,063,7201,611,9712,859,0005,904,0003,983,0007,035,0005,637,0009,164,0001,204,000−86.9%
Net profit1,103,5511,472,1412,166,0004,758,0003,008,0005,522,0004,352,0007,844,000963,000−87.7%
Total assets6,602,9428,460,99915,144,00021,143,00024,627,00030,278,00035,289,00045,811,00012,873,000−71.9%
Equity6,272,1928,014,36014,048,00019,121,00022,196,00027,441,00031,610,00036,697,0005,847,000−84.1%
Liabilities330,750446,6391,096,0002,022,0002,431,0002,837,0003,679,0009,114,0007,026,000−22.9%
Cash and cash equivalents1,347,545532,9073,552,0007,260,0008,957,0009,893,00014,867,0009,858,0001,715,000−82.6%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 1bnDKK 0DKK 1bnDKK 2bnDKK 3bnDKK 4bnDKK 5bnDKK 6bnDKK 7bnDKK 8bn201720182019202020212022202320242025
Net profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Equity fell sharply

    Equity fell 84% from 2024 to 2025 (DKK 36.7bn to DKK 5.8bn).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

9 financial years
Annual reports for Genmab A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202531/03/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202413/03/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202313/03/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202230/03/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202130/03/2022The companyPDF not statedXBRL
202001/01/2020 – 31/12/202019/04/2021The companyPDFXBRL
201901/01/2019 – 31/12/201926/03/2020The companyPDFXBRL
201801/01/2018 – 31/12/201829/03/2019The companyPDFXBRL
201701/01/2017 – 31/12/201710/04/2018The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
010020030040050060070008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

EquityDKK 5.8bnNo. 3 of 431
Better than 100% of the companies in the industry
Number of employees676No. 3 of 431
Better than 100% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale).

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 500–999 employees207 companies in the comparisonnot stated
No. 13of 207
Better than 94%
Companies that are between 15 and 29 years old24,910 companies in the comparisonnot stated
No. 44of 24,909
Better than 100%
All companies of type A/S18,025 companies in the comparisonnot stated
No. 92of 18,024
Better than 99%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Genmab A/S–
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Genmab A/SDKK 963m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Genmab A/SDKK 5.8bn
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Genmab A/S676
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Blackrock, Inc.5%
Genmab A/S

Management

13 active registrations

Executive management

Executive management at Genmab A/S
NameRoleAppointed
Jan van de WinkelCEO15/06/2010
Anthony Michael PaganoDirector01/03/2020

Board of directors

Board of directors at Genmab A/S
NameRoleAppointed
Paolo Augusto PaolettiBoard member26/03/2015
Rolf Karl Heinz HoffmannBoard member28/03/2017
Anders Gersel PedersenBoard member10/04/2018
Mijke ZachariasseBoard member22/03/2019
Deirdre Patrice ConnellyChair of the board26/03/2020
Pernille Lyngvold ErenbjergDeputy chair26/03/2020
Martin SchultzBoard member29/03/2022
Elizabeth Grimes O’FarrellBoard member29/03/2022
Ogi TakahashiDeputy board member12/03/2025
Martha Theresa Ramirez-AndersenDeputy board member12/03/2025
Gina Theresa SchweizerBoard member15/08/2026
Founders
Gorrissen Federspiel Komplementar Advokatanpartsselskab
Former management (58)
Former management at Genmab A/S
NameRoleAppointedResigned
Klaus SøgaardDirector11/06/199817/11/1998
Jan-Erik Gunnar SvenssonChair of the board11/06/199817/11/1998
Klaus SøgaardBoard member11/06/199817/11/1998
Troels Elkiær AndersenBoard member11/06/199817/11/1998
Eva SteinessChair of the board15/02/199922/12/1999
Ernst Jakob SchweizerBoard member25/02/199915/04/2009
Claus Juan Møller-San PedroDirector25/02/199903/09/2008
Jesper ZeuthenChair of the board25/02/199924/04/2003
Lisa Natale DrakemanBoard member25/02/199915/06/2010
Lisa Natale DrakemanDirector25/02/199915/06/2010
Leif Helth JensenBoard member02/02/200007/03/2002
Neil RimerBoard member21/07/200022/03/2001
Dwight KinseyBoard member21/07/200027/07/2000
Irwin LernerBoard member27/07/200031/01/2007
Michael Wolff JensenDirector27/07/200001/08/2003
Francesco de RubertisBoard member22/03/200107/03/2002
Zahad SubhanDirector01/10/200121/01/2002
Karsten Havkrog PedersenBoard member07/03/200217/04/2013
Alberto ElliDirector06/06/200505/08/2005
Bo KruseDirector21/09/200502/06/2008
Hans Henrik Munch-JensenBoard member19/04/200726/03/2015
David Andrew EatwellChief financial officer02/06/200801/03/2020
Daniel John BrunoBoard member02/06/201017/04/2013
Nedjad LosicBoard member02/06/201017/03/2016
Thomas OettingerDeputy board member02/06/201017/04/2013
Stephen Paul BryantDeputy board member02/06/201017/04/2013
Peter Hendrik RosDeputy board member02/06/201017/04/2013
Tom VinkBoard member02/06/201016/03/2016
Antonius Theodorus Maria WilderbeekBoard member06/04/201117/04/2013
Michael Blair WidmerBoard member25/04/201217/04/2013
Mats Gunnar PetterssonChair of the board17/04/201326/03/2020
Anders BoelskiftDeputy board member17/04/201330/09/2014
Anders Gersel PedersenDeputy chair17/04/201309/04/2018
Burton Gordon MalkielBoard member17/04/201328/03/2017
Barbara BrouwerDeputy board member17/04/201317/03/2016
Pernille Lyngvold ErenbjergBoard member26/03/201525/03/2020
Daniel John BrunoBoard member17/03/201617/08/2020
Richard Gordon HibbertBoard member17/03/201622/03/2019
Peter Storm KristensenBoard member17/03/201629/03/2022
Tom VinkDeputy board member17/03/201631/03/2017
Pernille Kristine HemmingsenDeputy board member17/03/201631/10/2017
Stephen Paul BryantDeputy board member17/03/201622/03/2019
Judith Viviana KlimovskyDirector13/02/201701/01/2023
Deirdre Patrice ConnellyBoard member28/03/201709/04/2018
Deirdre Patrice ConnellyDeputy chair10/04/201825/03/2020
Rima Bawarshi NassarDeputy board member22/03/201916/08/2020
Simone de HaijDeputy board member22/03/201929/03/2022
Nina HolstDeputy board member22/03/201929/03/2022
Anthony ManciniDirector23/03/202001/01/2023
Jonathan Michael PeacockBoard member26/03/202015/11/2021
Rima Bawarshi NassarBoard member17/08/202029/03/2022
Tahamtan AhmadiDirector01/03/202101/01/2023
Julie BlædelDeputy board member29/03/202212/03/2025
Suzana Sturlini CoutoDeputy board member29/03/202210/04/2023
Richard Gordon HibbertDeputy board member29/03/202212/03/2025
Takahiro HamataniBoard member29/03/202212/03/2025
Gina Theresa SchweizerDeputy board member12/03/202514/08/2026
Michael Arthur KavanaghBoard member12/03/202514/08/2026

Signing rule: Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af to bestyrelsesmedlemmer i forening.

Address and production units

2 active production units
Production units
Production unitAddressEmployeesP number
GENMAB A/SCarl Jacobsens Vej 30, 2500 Valby6981004824743
Genmab A/SBaltorpvej 154, 2750 Ballerup–1029560494

Purpose

Selskabets formål er at udøve medicinsk forskning, produktion og salg af sådanne produkter samt anden dermed i forbindelse stående virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

290 registered events
202611 changesownership 1 · capital 6 · management 3 · accounts 1
  • Darwin Global Management Limited registered as owner (0%)
  • Share capital changed from 62,377,844 DKK to 62,405,855 DKK
  • Gina Theresa Schweizer appointed board member
  • Michael Arthur Kavanagh stepped down as board member
  • Gina Theresa Schweizer stepped down as deputy board member
  • Share capital changed from 62,353,252 DKK to 62,377,844 DKK
  • Share capital changed from 62,353,067 DKK to 62,353,252 DKK
  • Share capital changed from 62,350,721 DKK to 62,353,067 DKK
  • Share capital changed from 64,250,721 DKK to 62,350,721 DKK
  • Annual report for 2025 published
  • Share capital changed from 64,238,408 DKK to 64,250,721 DKK
202516 changescapital 7 · accounts 1 · management 7 · industry 1
  • Share capital changed from 64,206,349 DKK to 64,238,408 DKK
  • Share capital changed from 64,158,817 DKK to 64,206,349 DKK
  • Share capital changed from 64,154,254 DKK to 64,158,817 DKK
  • Share capital changed from 64,122,137 DKK to 64,154,254 DKK
  • Share capital changed from 64,120,391 DKK to 64,122,137 DKK
  • Share capital changed from 66,197,244 DKK to 64,120,391 DKK
  • Annual report for 2024 published
  • Ogi Takahashi appointed deputy board member
  • Michael Arthur Kavanagh appointed board member
  • Martha Theresa Ramirez-Andersen appointed deputy board member
  • Gina Theresa Schweizer appointed deputy board member
  • Takahiro Hamatani stepped down as board member
  • Richard Gordon Hibbert stepped down as deputy board member
  • Julie Blædel stepped down as deputy board member
  • Share capital changed from 66,187,186 DKK to 66,197,244 DKK
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20247 changescapital 6 · accounts 1
  • Share capital changed from 66,176,831 DKK to 66,187,186 DKK
  • Share capital changed from 66,165,102 DKK to 66,176,831 DKK
  • Share capital changed from 66,136,909 DKK to 66,165,102 DKK
  • Share capital changed from 66,129,923 DKK to 66,136,909 DKK
  • Share capital changed from 66,122,964 DKK to 66,129,923 DKK
  • Annual report for 2023 published
  • Share capital changed from 66,074,535 DKK to 66,122,964 DKK
202313 changescapital 6 · ownership 1 · address 1 · management 4 · accounts 1
  • Share capital changed from 66,067,481 DKK to 66,074,535 DKK
  • Wellington Management Group LLP is no longer registered as owner
  • Share capital changed from 66,057,125 DKK to 66,067,481 DKK
  • Share capital changed from 66,038,425 DKK to 66,057,125 DKK
  • Moved to Carl Jacobsens Vej 30, 2500 Valby
  • Share capital changed from 66,019,030 DKK to 66,038,425 DKK
  • Share capital changed from 65,985,932 DKK to 66,019,030 DKK
  • Suzana Sturlini Couto stepped down as deputy board member
  • Annual report for 2022 published
  • Share capital changed from 65,961,573 DKK to 65,985,932 DKK
  • Tahamtan Ahmadi stepped down as director
  • Anthony Mancini stepped down as director
  • Judith Viviana Klimovsky stepped down as director
202223 changescapital 7 · ownership 5 · accounts 1 · management 10
  • Share capital changed from 65,886,724 DKK to 65,961,573 DKK
  • Share capital changed from 65,829,282 DKK to 65,886,724 DKK
  • Wellington Management Group LLP registered as owner (5%)
  • Share capital changed from 65,810,876 DKK to 65,829,282 DKK
  • Share capital changed from 65,764,435 DKK to 65,810,876 DKK
  • Wellington Management Group LLP is no longer registered as owner
  • Wellington Management Group LLP registered as owner (5%)
  • Share capital changed from 65,753,443 DKK to 65,764,435 DKK
  • Wellington Management Group LLP is no longer registered as owner
  • Wellington Management Group LLP registered as owner (5%)
  • Share capital changed from 65,734,141 DKK to 65,753,443 DKK
  • Annual report for 2021 published
  • Elizabeth Grimes O’Farrell appointed board member
  • Martin Schultz appointed board member
  • Takahiro Hamatani appointed board member
  • Richard Gordon Hibbert appointed deputy board member
  • Suzana Sturlini Couto appointed deputy board member
  • Julie Blædel appointed deputy board member
  • Rima Bawarshi Nassar stepped down as board member
  • Nina Holst stepped down as deputy board member
  • Simone de Haij stepped down as deputy board member
  • Peter Storm Kristensen stepped down as board member
  • Share capital changed from 65,718,456 DKK to 65,734,141 DKK
202111 changescapital 7 · management 2 · ownership 1 · accounts 1
  • Share capital changed from 65,702,915 DKK to 65,718,456 DKK
  • Share capital changed from 65,685,053 DKK to 65,702,915 DKK
  • Jonathan Michael Peacock stepped down as board member
  • Share capital changed from 65,681,084 DKK to 65,685,053 DKK
  • Share capital changed from 65,668,714 DKK to 65,681,084 DKK
  • Artisan Partners Ltd. Partnership is no longer registered as owner
  • Share capital changed from 65,620,740 DKK to 65,668,714 DKK
  • Share capital changed from 65,587,322 DKK to 65,620,740 DKK
  • Annual report for 2020 published
  • Share capital changed from 65,545,748 DKK to 65,587,322 DKK
  • Tahamtan Ahmadi appointed director
202022 changescapital 7 · management 12 · ownership 2 · accounts 1
  • Share capital changed from 65,498,346 DKK to 65,545,748 DKK
  • Share capital changed from 65,409,296 DKK to 65,498,346 DKK
  • Share capital changed from 65,346,580 DKK to 65,409,296 DKK
  • Rima Bawarshi Nassar appointed board member
  • Daniel John Bruno stepped down as board member
  • Rima Bawarshi Nassar stepped down as deputy board member
  • Société Générale S.A. is no longer registered as owner
  • Share capital changed from 65,280,093 DKK to 65,346,580 DKK
  • Société Générale S.A. registered as owner (5%)
  • Share capital changed from 65,211,003 DKK to 65,280,093 DKK
  • Share capital changed from 65,156,578 DKK to 65,211,003 DKK
  • Jonathan Michael Peacock appointed board member
  • Deirdre Patrice Connelly appointed chair of the board
  • Pernille Lyngvold Erenbjerg appointed deputy chair
  • Mats Gunnar Pettersson stepped down as chair of the board
  • Annual report for 2019 published
  • Deirdre Patrice Connelly stepped down as deputy chair
  • Pernille Lyngvold Erenbjerg stepped down as board member
  • Anthony Mancini appointed director
  • Anthony Michael Pagano appointed director
  • David Andrew Eatwell stepped down as chief financial officer
  • Share capital changed from 65,074,502 DKK to 65,156,578 DKK
201918 changescapital 8 · ownership 3 · accounts 1 · management 6
  • Share capital changed from 65,018,173 DKK to 65,074,502 DKK
  • Share capital changed from 64,989,454 DKK to 65,018,173 DKK
  • Share capital changed from 64,967,643 DKK to 64,989,454 DKK
  • BLACKROCK, INC. registered as owner (5%)
  • Share capital changed from 61,690,143 DKK to 64,967,643 DKK
  • Share capital changed from 61,680,566 DKK to 61,690,143 DKK
  • BLACKROCK, INC. is no longer registered as owner
  • BLACKROCK, INC. registered as owner (5%)
  • Share capital changed from 61,670,829 DKK to 61,680,566 DKK
  • Share capital changed from 61,523,868 DKK to 61,670,829 DKK
  • Annual report for 2018 published
  • Rima Bawarshi Nassar appointed deputy board member
  • Mijke Zachariasse appointed board member
  • Nina Holst appointed deputy board member
  • Simone de Haij appointed deputy board member
  • Stephen Paul Bryant stepped down as deputy board member
  • Richard Gordon Hibbert stepped down as board member
  • Share capital changed from 61,497,571 DKK to 61,523,868 DKK
201815 changescapital 7 · address 1 · ownership 2 · management 4 · accounts 1
  • Share capital changed from 61,489,983 DKK to 61,497,571 DKK
  • Moved to Kalvebod Brygge 43, 1560 København V
  • Share capital changed from 61,471,569 DKK to 61,489,983 DKK
  • Share capital changed from 61,460,843 DKK to 61,471,569 DKK
  • BLACKROCK, INC. is no longer registered as owner
  • Share capital changed from 61,436,818 DKK to 61,460,843 DKK
  • Share capital changed from 61,281,242 DKK to 61,436,818 DKK
  • Deirdre Patrice Connelly appointed deputy chair
  • Anders Gersel Pedersen appointed board member
  • Annual report for 2017 published
  • Deirdre Patrice Connelly stepped down as board member
  • Anders Gersel Pedersen stepped down as deputy chair
  • Share capital changed from 61,251,093 DKK to 61,281,242 DKK
  • Share capital changed from 61,185,674 DKK to 61,251,093 DKK
  • Artisan Partners Ltd. Partnership registered as owner (5%)
201715 changescapital 7 · ownership 1 · management 6 · address 1
  • Share capital changed from 61,163,142 DKK to 61,185,674 DKK
  • BLACKROCK, INC. registered as owner (5%)
  • Pernille Kristine Hemmingsen stepped down as deputy board member
  • Share capital changed from 61,139,472 DKK to 61,163,142 DKK
  • Share capital changed from 61,118,402 DKK to 61,139,472 DKK
  • Share capital changed from 60,955,238 DKK to 61,118,402 DKK
  • Moved to Kalvebod Brygge 43, 1560 København V
  • Share capital changed from 60,911,986 DKK to 60,955,238 DKK
  • Share capital changed from 60,735,143 DKK to 60,911,986 DKK
  • Tom Vink stepped down as deputy board member
  • Rolf Karl Heinz Hoffmann appointed board member
  • Deirdre Patrice Connelly appointed board member
  • Burton Gordon Malkiel stepped down as board member
  • Share capital changed from 60,350,056 DKK to 60,735,143 DKK
  • Judith Viviana Klimovsky appointed director
201616 changescapital 5 · ownership 2 · management 9
  • Share capital changed from 60,248,597 DKK to 60,350,056 DKK
  • Share capital changed from 60,181,757 DKK to 60,248,597 DKK
  • FMR LLC (Fidelity Management and Research) is no longer registered as owner
  • Share capital changed from 59,833,932 DKK to 60,181,757 DKK
  • Share capital changed from 59,677,584 DKK to 59,833,932 DKK
  • Peter Storm Kristensen appointed board member
  • Stephen Paul Bryant appointed deputy board member
  • Daniel John Bruno appointed board member
  • Tom Vink appointed deputy board member
  • Pernille Kristine Hemmingsen appointed deputy board member
  • Richard Gordon Hibbert appointed board member
  • Barbara Brouwer stepped down as deputy board member
  • Nedjad Losic stepped down as board member
  • Tom Vink stepped down as board member
  • Share capital changed from 59,531,263 DKK to 59,677,584 DKK
  • Johnson & Johnson Innovation-JJDC, Inc. is no longer registered as owner
201511 changescapital 4 · ownership 4 · management 3
  • Share capital changed from 59,322,130 DKK to 59,531,263 DKK
  • FMR LLC (Fidelity Management and Research) registered as owner (5%)
  • FMR LLC (Fidelity Management and Research) is no longer registered as owner
  • Share capital changed from 58,717,499 DKK to 59,322,130 DKK
  • Arbejdsmarkedets Tillægspension is no longer registered as owner
  • Share capital changed from 58,133,664 DKK to 58,717,499 DKK
  • Pernille Lyngvold Erenbjerg appointed board member
  • Paolo Augusto Paoletti appointed board member
  • Hans Henrik Munch-Jensen stepped down as board member
  • Share capital changed from 56,967,419 DKK to 58,133,664 DKK
  • GlaxoSmithKline plc is no longer registered as owner
20147 changescapital 5 · management 1 · ownership 1
  • Share capital changed from 56,821,271 DKK to 56,967,419 DKK
  • Anders Boelskift stepped down as deputy board member
  • Share capital changed from 56,687,266 DKK to 56,821,271 DKK
  • Share capital changed from 56,629,202 DKK to 56,687,266 DKK
  • Share capital changed from 56,355,722 DKK to 56,629,202 DKK
  • Johnson & Johnson Innovation-JJDC, Inc. registered as owner (5%)
  • Share capital changed from 51,755,722 DKK to 56,355,722 DKK
201318 changesownership 2 · capital 4 · management 12
  • FMR LLC (Fidelity Management and Research) registered as owner (5%)
  • Share capital changed from 51,210,696 DKK to 51,755,722 DKK
  • Share capital changed from 51,052,818 DKK to 51,210,696 DKK
  • Share capital changed from 50,712,892 DKK to 51,052,818 DKK
  • Barbara Brouwer appointed deputy board member
  • Anders Boelskift appointed deputy board member
  • Anders Gersel Pedersen appointed deputy chair
  • Burton Gordon Malkiel appointed board member
  • Mats Gunnar Pettersson appointed chair of the board
  • Michael Blair Widmer stepped down as board member
  • Antonius Theodorus Maria Wilderbeek stepped down as board member
  • Daniel John Bruno stepped down as board member
  • Peter Hendrik Ros stepped down as deputy board member
  • Stephen Paul Bryant stepped down as deputy board member
  • Thomas Oettinger stepped down as deputy board member
  • Karsten Havkrog Pedersen stepped down as board member
  • Share capital changed from 50,307,892 DKK to 50,712,892 DKK
  • Arbejdsmarkedets Tillægspension registered as owner (5%)
20124 changescapital 2 · address 1 · management 1
  • Share capital changed from 50,307,142 DKK to 50,307,892 DKK
  • Moved to Bredgade 34E, 1260 København K
  • Share capital changed from 44,907,142 DKK to 50,307,142 DKK
  • Michael Blair Widmer appointed board member
20111 changemanagement 1
  • Antonius Theodorus Maria Wilderbeek appointed board member
20107 changesmanagement 7
  • Jan van de Winkel appointed ceo
  • Daniel John Bruno appointed board member
  • Peter Hendrik Ros appointed deputy board member
  • Stephen Paul Bryant appointed deputy board member
  • Thomas Oettinger appointed deputy board member
  • Nedjad Losic appointed board member
  • Tom Vink appointed board member
20093 changescapital 2 · address 1
  • Share capital changed from 44,906,042 DKK to 44,907,142 DKK
  • Share capital changed from 44,888,829 DKK to 44,906,042 DKK
  • Moved to Bredgade 34, 1260 København K
20087 changescapital 3 · ownership 1 · management 2 · industry 1
  • Share capital changed from 44,735,466 DKK to 44,888,829 DKK
  • GlaxoSmithKline plc registered as owner (5%)
  • Share capital changed from 44,583,648 DKK to 44,735,466 DKK
  • David Andrew Eatwell appointed chief financial officer
  • Bo Kruse stepped down as director
  • Share capital changed from 44,519,827 DKK to 44,583,648 DKK
  • Industry changed to Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)
20077 changescapital 5 · management 2
  • Share capital changed from 44,506,216 DKK to 44,519,827 DKK
  • Share capital changed from 44,464,556 DKK to 44,506,216 DKK
  • Share capital changed from 44,333,015 DKK to 44,464,556 DKK
  • Hans Henrik Munch-Jensen appointed board member
  • Share capital changed from 44,119,557 DKK to 44,333,015 DKK
  • Share capital changed from 39,648,355 DKK to 44,119,557 DKK
  • Irwin Lerner stepped down as board member
20067 changescapital 7
  • Share capital changed from 39,647,855 DKK to 39,648,355 DKK
  • Share capital changed from 39,569,874 DKK to 39,647,855 DKK
  • Share capital changed from 39,470,287 DKK to 39,569,874 DKK
  • Share capital changed from 39,424,413 DKK to 39,470,287 DKK
  • Share capital changed from 39,196,765 DKK to 39,424,413 DKK
  • Share capital changed from 38,858,098 DKK to 39,196,765 DKK
  • Share capital changed from 33,108,098 DKK to 38,858,098 DKK
200512 changescapital 9 · management 3
  • Share capital changed from 33,093,948 DKK to 33,108,098 DKK
  • Share capital changed from 33,061,573 DKK to 33,093,948 DKK
  • Bo Kruse appointed director
  • Share capital changed from 33,054,823 DKK to 33,061,573 DKK
  • Share capital changed from 30,556,316 DKK to 33,054,823 DKK
  • Alberto Elli stepped down as director
  • Share capital changed from 30,541,216 DKK to 30,556,316 DKK
  • Share capital changed from 30,329,816 DKK to 30,541,216 DKK
  • Alberto Elli appointed director
  • Share capital changed from 30,055,404 DKK to 30,329,816 DKK
  • Share capital changed from 30,025,854 DKK to 30,055,404 DKK
  • Share capital changed from 29,752,363 DKK to 30,025,854 DKK
200410 changescapital 10
  • Share capital changed from 29,744,958 DKK to 29,752,363 DKK
  • Share capital changed from 29,454,132 DKK to 29,744,958 DKK
  • Share capital changed from 23,831,132 DKK to 29,454,132 DKK
  • Share capital changed from 23,597,757 DKK to 23,831,132 DKK
  • Share capital changed from 23,293,382 DKK to 23,597,757 DKK
  • Share capital changed from 23,290,883 DKK to 23,293,382 DKK
  • Share capital changed from 23,278,133 DKK to 23,290,883 DKK
  • Share capital changed from 23,234,133 DKK to 23,278,133 DKK
  • Share capital changed from 23,164,034 DKK to 23,234,133 DKK
  • Share capital changed from 22,980,534 DKK to 23,164,034 DKK
20034 changescapital 3 · management 1
  • Share capital changed from 22,978,534 DKK to 22,980,534 DKK
  • Share capital changed from 22,963,534 DKK to 22,978,534 DKK
  • Michael Wolff Jensen stepped down as director
  • Share capital changed from 22,716,620 DKK to 22,963,534 DKK
20027 changesaddress 1 · capital 3 · management 3
  • Moved to Toldbodgade 33, 1253 København K
  • Share capital changed from 21,836,520 DKK to 22,716,620 DKK
  • Karsten Havkrog Pedersen appointed board member
  • Francesco de Rubertis stepped down as board member
  • Share capital changed from 21,826,520 DKK to 21,836,520 DKK
  • Zahad Subhan stepped down as director
  • Share capital changed from 21,812,020 DKK to 21,826,520 DKK
20013 changesmanagement 3
  • Zahad Subhan appointed director
  • Francesco de Rubertis appointed board member
  • Neil Rimer stepped down as board member
200011 changescapital 4 · management 5 · industry 1 · address 1
  • Share capital changed from 15,812,020 DKK to 21,812,020 DKK
  • Share capital changed from 1,553,226 DKK to 15,812,020 DKK
  • Irwin Lerner appointed board member
  • Michael Wolff Jensen appointed director
  • Dwight Kinsey stepped down as board member
  • Neil Rimer appointed board member
  • Dwight Kinsey appointed board member
  • Share capital changed from 973,440 DKK to 1,553,226 DKK
  • Industry changed to Forskning og udvikling inden for naturvidenskab og teknik (731000)
  • Share capital changed from 671,692 DKK to 973,440 DKK
  • Moved to Bredgade 23A, 3, 1260 København K
19992 changescapital 2
  • Share capital changed from 500,000 DKK to 671,692 DKK
  • Share capital changed from 125,000 DKK to 500,000 DKK
19982 changesname 1 · founded 1
  • Name changed from GFKJUS 519 ApS to GENMAB A/S
  • Registered as GFKJUS 519 ApS

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 23/10/2026.

View in CVRReport a correction